OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut–CNS Axis in Multiple Sclerosis
Atsushi Kadowaki, Francisco J. Quintana
Trends in Neurosciences (2020) Vol. 43, Iss. 8, pp. 622-634
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials
Jinchi Jiang, Chuanqi Chu, Caie Wu, et al.
Food & Function (2021) Vol. 12, Iss. 6, pp. 2354-2377
Closed Access | Times Cited: 38

Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
Nicholas Dopkins, Kathryn Miranda, Kiesha Wilson, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 17, Iss. 1-2, pp. 15-32
Open Access | Times Cited: 35

The gut microbiome: implications for neurogenesis and neurological diseases
Fang Zhou, Cheng Liu, Shang‐Yu Yang, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 1, pp. 53-53
Open Access | Times Cited: 34

The Efficacy of Fecal Microbiota Transplantation in Experimental Autoimmune Encephalomyelitis: Transcriptome and Gut Microbiota Profiling
Sanwang Wang, Hongliang Chen, Xin Wen, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 30

The gut microbiota as a biomarker in epilepsy
Emilio Russo
Neurobiology of Disease (2021) Vol. 163, pp. 105598-105598
Open Access | Times Cited: 29

Mechanisms underlying the beneficial effects of physical exercise on multiple sclerosis: focus on immune cells
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Microbiota Metabolites and Immune Regulation Affect Ischemic Stroke Occurrence, Development, and Prognosis
Tao Wang, Chuan-Ling Pan, Cheng Xie, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6176-6187
Closed Access | Times Cited: 11

Propionic acid promotes neurite recovery in damaged multiple sclerosis neurons
Barbara Gisevius, Alexander Duscha, Gereon Poschmann, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 4

Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression
Daniele Lana, Filippo Ugolini, Ludovica Iovino, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 18
Open Access

Role of microbiota-gut-brain axis in autoimmunity and multiple sclerosis
Yogesh Mishra, Dipan Maity, Ravinder K. Kaundal
Elsevier eBooks (2025), pp. 161-191
Closed Access

Microbiota-produced immune regulatory bile acid metabolites control central nervous system autoimmunity
Martina Antonini Cencicchio, Federico Montini, Vittoria Palmieri, et al.
Cell Reports Medicine (2025), pp. 102028-102028
Open Access

Neuroglia and the microbiota-gut-brain axis
H. Blair, Lorena Morales, John F. Cryan, et al.
Handbook of clinical neurology (2025), pp. 171-196
Closed Access

Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Alessandro Maglione, Miriam Zuccalà, Martina Tosi, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1181-1181
Open Access | Times Cited: 26

NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases—Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome
Michał Zarobkiewicz, Izabela Morawska, Adam Michalski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9520-9520
Open Access | Times Cited: 25

Role of Gut Microbiota in Pulmonary Arterial Hypertension
Panyun Wu, Tengteng Zhu, Zhen Tan, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 17

The Probable Infectious Origin of Multiple Sclerosis
Remi L. Landry, Monica E. Embers
NeuroSci (2023) Vol. 4, Iss. 3, pp. 211-234
Open Access | Times Cited: 9

Wrapping Things Up: Recent Developments in Understanding the Role of the Microbiome in Regulating Myelination
Caoimhe M.K. Lynch, Jatin Nagpal, Gerard Clarke, et al.
Current Opinion in Physiology (2021) Vol. 23, pp. 100468-100468
Closed Access | Times Cited: 20

The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases
Miaomiao Han, Xinrong Yuan, Xiang Shi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19

Obesity and the Brain
Jacek Karczewski, Aleksandra Zielińska, R. Staszewski, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6145-6145
Open Access | Times Cited: 12

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
Eduardo Duarte-Silva, Henning Ulrich, Ágatha Oliveira‐Giacomelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

Host–gut microbiota crosstalk predicts neuroinflammation
Carolina Manganeli Polonio, Francisco J. Quintana
Nature Microbiology (2024) Vol. 9, Iss. 9, pp. 2204-2205
Closed Access | Times Cited: 2

Looking at the full picture, using topic modeling to observe microbiome communities associated with disease
Rachel L. Fitzjerrells, Nicholas J. Ollberding, Ashutosh K. Mangalam
Gut Microbes Reports (2024) Vol. 1, Iss. 1, pp. 1-11
Open Access | Times Cited: 2

Scroll to top